Synopsis
Synopsis
0
CEP/COS
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
| Molecular Weight | 868.8 g/mol |
|---|---|
| Molecular Formula | C42H36CaO18 |
| Hydrogen Bond Donor Count | 10 |
| Hydrogen Bond Acceptor Count | 18 |
| Rotatable Bond Count | 4 |
| Exact Mass | 868.1527551 g/mol |
| Monoisotopic Mass | 868.1527551 g/mol |
| Topological Polar Surface Area | 335 Ų |
| Heavy Atom Count | 61 |
| Formal Charge | 0 |
| Complexity | 1520 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 12 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
ABOUT THIS PAGE
53
PharmaCompass offers a list of Calcium Sennoside API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Calcium Sennoside manufacturer or Calcium Sennoside supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Calcium Sennoside manufacturer or Calcium Sennoside supplier.
PharmaCompass also assists you with knowing the Calcium Sennoside API Price utilized in the formulation of products. Calcium Sennoside API Price is not always fixed or binding as the Calcium Sennoside Price is obtained through a variety of data sources. The Calcium Sennoside Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Calcium Sennoside manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Calcium Sennoside, including repackagers and relabelers. The FDA regulates Calcium Sennoside manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Calcium Sennoside API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Calcium Sennoside manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Calcium Sennoside supplier is an individual or a company that provides Calcium Sennoside active pharmaceutical ingredient (API) or Calcium Sennoside finished formulations upon request. The Calcium Sennoside suppliers may include Calcium Sennoside API manufacturers, exporters, distributors and traders.
click here to find a list of Calcium Sennoside suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Calcium Sennoside DMF (Drug Master File) is a document detailing the whole manufacturing process of Calcium Sennoside active pharmaceutical ingredient (API) in detail. Different forms of Calcium Sennoside DMFs exist exist since differing nations have different regulations, such as Calcium Sennoside USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Calcium Sennoside DMF submitted to regulatory agencies in the US is known as a USDMF. Calcium Sennoside USDMF includes data on Calcium Sennoside's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Calcium Sennoside USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Calcium Sennoside suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Calcium Sennoside Drug Master File in Japan (Calcium Sennoside JDMF) empowers Calcium Sennoside API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Calcium Sennoside JDMF during the approval evaluation for pharmaceutical products. At the time of Calcium Sennoside JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Calcium Sennoside suppliers with JDMF on PharmaCompass.
A Calcium Sennoside written confirmation (Calcium Sennoside WC) is an official document issued by a regulatory agency to a Calcium Sennoside manufacturer, verifying that the manufacturing facility of a Calcium Sennoside active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Calcium Sennoside APIs or Calcium Sennoside finished pharmaceutical products to another nation, regulatory agencies frequently require a Calcium Sennoside WC (written confirmation) as part of the regulatory process.
click here to find a list of Calcium Sennoside suppliers with Written Confirmation (WC) on PharmaCompass.
Calcium Sennoside Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Calcium Sennoside GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Calcium Sennoside GMP manufacturer or Calcium Sennoside GMP API supplier for your needs.
A Calcium Sennoside CoA (Certificate of Analysis) is a formal document that attests to Calcium Sennoside's compliance with Calcium Sennoside specifications and serves as a tool for batch-level quality control.
Calcium Sennoside CoA mostly includes findings from lab analyses of a specific batch. For each Calcium Sennoside CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Calcium Sennoside may be tested according to a variety of international standards, such as European Pharmacopoeia (Calcium Sennoside EP), Calcium Sennoside JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Calcium Sennoside USP).
